
Gylus Pharmaceuticals Private Limited
About Gylus Pharmaceuticals Private Limited
Data last updated:
Gylus Pharmaceuticals Private Limited is a private limited company based in Hamirpur, Himachal Pradesh, India. It operates in the retail trading segment of the trading and commerce sector. It was incorporated on 24 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24304HP2016PTC006378. Its GSTIN is 02AAGCG5720N1ZM (Himachal Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anoop Singh Lohiya and Naresh Kumar.
Its last annual general meeting (AGM) was held on 11 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Near Old Thakur Nursing Home Barsar, Hamirpur, Himachal Pradesh, India – 174305.
As per the financials filed for FY 2023, the company reported a revenue of ₹66.91 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹6.01 Lakh (net margin -9%) and EBITDA of -₹4.99 Lakh (EBITDA margin -7.5%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 30% over five years.
Court records list 3 cases involving the company, including 3 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Gylus Pharmaceuticals Private Limited's registered office is in Hamirpur, Himachal Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNear Old Thakur Nursing Home Barsar, Hamirpur, Himachal Pradesh, India – 174305
- IndustryTrading, Retail Trading, Retailers
To see the full contact details of Gylus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gylus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Gylus Pharmaceuticals Private Limited, buy the company report.
Financials of Gylus Pharmaceuticals Private Limited
FY 2023 filings availableGylus Pharmaceuticals Private Limited reported revenue of ₹66.91 Lakh (up 29% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years, including 29% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -7.5% | ||||
| Net Profit Margin | -9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gylus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Gylus Pharmaceuticals Private Limited
Gylus Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anoop Singh Lohiya Also directs: Gylus Biotech Private Limited | Director | 24 Oct 2016 | 10 Years 0 Months | Current |
| Naresh Kumar | Director | 24 Oct 2016 | 10 Years 0 Months | Current |
Peer comparison
Gylus Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Waxemon Pharmaceuticals (OPC) Private Limited | ₹67.52 Lakh (FY 2025) | 2.0% | Lucknow, Uttar Pradesh, India | |||
| Seramic Pharmaceuticals Private Limited | ₹67.42 Lakh (FY 2025) | -49.0% | Bhiwandi, Maharashtra, India | |||
| Jigson Pharmaceuticals Private Limited | ₹67.17 Lakh (FY 2025) | 4.0% | Ahmedabad, Gujarat, India | |||
| Gylus Pharmaceuticals Private Limitedthis company | ₹66.91 Lakh (FY 2023) | -₹6.01 Lakh | -9% | 29.0% | Hamirpur, Himachal Pradesh, India | |
| Rcsat Pharmaceuticals Private Limited | ₹66.71 Lakh (FY 2025) | -38.0% | Meerut, Uttar Pradesh, India | |||
| Equinox Pharmaceuticals Private Limited | ₹66.64 Lakh (FY 2025) | 27.0% | Patna, Bihar, India |
To see the full peer comparison of Gylus Pharmaceuticals Private Limited, buy the company report.
Auditor
Gylus Pharmaceuticals Private Limited is audited by Rajesh Sharma & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rajesh Sharma & Associates | FY 2017 | 538641 |
Shareholding
The shareholding of Gylus Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Gylus Pharmaceuticals Private Limited, buy the company report.
Legal cases
Gylus Pharmaceuticals Private Limited has 3 court cases on record: 3 filed against it. 2 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hamirpur, Himachal Pradesh | Civil suit | Filed against the company by an individual | Pending |
| District court, Hamirpur, Himachal Pradesh | Civil miscellaneous application | Filed against the company by an individual | Pending |
| District court, Hamirpur, Himachal Pradesh | Court case (Cr. M. A.) | Filed against the company by an individual | Disposed |
To see the full case history of Gylus Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gylus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gylus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAGCG5720N1ZM | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gylus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Gylus Pharmaceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Prince Kumar ceased to be Director on 03 Jul 2024.
Frequently asked questions
Gylus Pharmaceuticals is an active private limited company based in Hamirpur, Himachal Pradesh, India. The company works in retail trading, within the trading industry. It was incorporated on 24 October 2016 (10+ years old) and is registered under CIN U24304HP2016PTC006378.
Gylus Pharmaceuticals has 2 current directors:
- Anoop Singh Lohiya - Director
- Naresh Kumar - Director
The latest financial statements of Gylus Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 11 September 2023. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Gylus Pharmaceuticals is 02AAGCG5720N1ZM, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Gylus Pharmaceuticals is U24304HP2016PTC006378. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gylus Pharmaceuticals has 3 court cases on record: 3 filed against it. 2 are pending.
Gylus Pharmaceuticals was incorporated on 24 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Gylus Pharmaceuticals by revenue are Waxemon Pharmaceuticals (OPC) Private Limited, Seramic Pharmaceuticals Private Limited, Jigson Pharmaceuticals Private Limited, Rcsat Pharmaceuticals Private Limited, Equinox Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Prince Kumar ceased to be Director on 03 Jul 2024. Mukesh Kumar ceased to be Director on 09 Nov 2018. Samridhi Minhas ceased to be Director on 27 Mar 2018. Gylus Pharmaceuticals has 5 board changes on record in total.
The registered office of Gylus Pharmaceuticals is at Near Old Thakur Nursing Home Barsar, Hamirpur, Himachal Pradesh, India – 174305.
Gylus Pharmaceuticals operates in the trading industry, in the retail trading segment.

